Understanding the clinical trial journey for patients with OCD
Understanding the Patient Perspective: An Observational Study on Experiences of OCD Clinical Trial Patients
Power Life Sciences Inc. · NCT05881356
This study looks at the experiences of people with OCD in clinical trials to see what makes it hard for them to join or finish these studies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Power Life Sciences Inc. (industry) |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT05881356 on ClinicalTrials.gov |
What this trial studies
This research collects data on the clinical trial experiences of patients with Obsessive-Compulsive Disorder (OCD) to identify factors that hinder their participation or completion of trials. The study aims to analyze demographic trends and trial attributes that may influence patient involvement. By gathering insights from various groups, the research seeks to enhance future clinical trial designs and improve accessibility for OCD patients.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with OCD who can provide informed consent and are willing to participate in the research.
Not a fit: Patients who are pregnant, lactating, or have conditions preventing informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved clinical trial designs that better accommodate OCD patients, increasing their participation rates.
How similar studies have performed: While there is limited research specifically on OCD trial participation, similar studies in other conditions have shown that understanding patient experiences can lead to improved trial designs.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed. * Participant has a diagnosis of OCD. * Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study. Exclusion Criteria: * Pregnant or lactating woman * Enrolled in another research study * Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
Where this trial is running
San Francisco, California
- Power Life Sciences — San Francisco, California, United States (RECRUITING)
Study contacts
- Study coordinator: Michael B Gill
- Email: bask@withpower.com
- Phone: 415-900-4227
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: OCD, Obsessive-Compulsive Disorder